2019
Risk factors for lymph nodes involvement in obese women with endometrial carcinomas
Sequential therapeutic targeting of ovarian Cancer harboring dysfunctional BRCA1
Triple tracer (blue dye, indocyanine green, and Tc99) compared to double tracer (indocyanine green and Tc99) for sentinel lymph node detection in endometrial cancer: a prospective study with random assignment.
2018
Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer
Oncologic and Surgical Outcomes of Robotic Versus Open Radical Hysterectomy for Cervical Cancer
Risk of Thromboembolic Disease With Cost Estimates in Patients Undergoing Robotic Assisted Surgery for Endometrial Cancer an Review of the Literature
Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis
2017
Absence of cardiotoxicity with prolonged treatment and large accumulating doses of pegylated liposomal doxorubicin
Clinical outcome of neoadjuvant chemotherapy for advanced ovarian cancer
Dose dense carboplatin paclitaxel improves progression free survival in patients with endometrial cancer
Impact of sentinel lymph node mapping on recurrence patterns in endometrial cancer
Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors
Outside the operating room: How a robotics program changed resource utilization on the inpatient ward
Unexpected locations of sentinel lymph nodes in endometrial cancer
2016
Benefits of Minimal Access Surgery in Elderly Patients with Pelvic Cancer
Molecular Basis of Gynecologic Cancers: What Should We Know?
Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines
Minimizing pain medication use and its associated costs following robotic surgery
2015
Outcome of Robotic Surgery for Endometrial Cancer as a Function of Patient Age
Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition
Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical
Health-Related Quality of Life Following Robotic Surgery: A Pilot Study trials involving PARP inhibitors sensitizes cancer cells to PARP inhibitors
Current Role of Sentinel Lymph Node Mapping in Endometrial Cancer
Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer
2014
Impact of robotics on the outcome of elderly patients with endometrial cancer
Health-Related Quality of Life Following Robotic Surgery: A Pilot Study
Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer
Prospective Quality of Life Outcomes Following Robotic Surgery in Gynecologic Oncology
2013
Benefits of robotic surgery for elderly patients with endometrial carcinoma
ESGO book chapter: Molecular Basics of Gynecologic Cancers
Vaginal Vault Dehiscence After Robotic Hysterectomy for Gynecologic Cancers
2012
Outcomes and Cost Comparisons After Introducing a Robotics Program for Endometrial Cancer Surgery
Accuracy of sentinel lymph node detection following intra-operative cervical injection for endometrial cancer: A prospective study
2011
Molecular Basis of Gynecologic Cancers
Relevance of the OCT1 transporter to the antineoplastic effect of biguanides
2010
Technical modifications in the robotic-assisted surgical approach for gynaecologic operations
2009
The Fallopian Tube
BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide
Genetic alterations detected by comparative genomic hybridization and recurrence rate in epithelial ovarian carcinoma
2008
Post-operative ascites following lymphadenectomy for early stage endometrial cancer
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
2007
Sarcoma post-embolization for presumed uterine fibroids
2006
Doxorubicin levels in the serum and ascites of patients with ovarian cancer
2005
Insulin-like growth factor receptor I targeting in epithelial ovarian cancer